Tapewire

Nasdaq · USD

DNLI

Denali Therapeutics Inc.

Export transactions ↓
Tapewire entity
1735
SEC CIK
0001714899
Parsed reports
436

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 16, 2024 Filed Jan 18, 2024 23:26 UTC
SATO VICKI LDirector
SaleCommon Stock 1,666 $18.42 $30,687.72
Disclosure

SEC source: 0001714899-24-000041 · wk-form4_1705620357.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,041

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $18.13 to $18.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 4,216 RSUs.

Read SEC document
January 10, 2024 Filed Jan 13, 2024 01:18 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 4,668 $19.02 $88,785.36
Disclosure

SEC source: 0001714899-24-000040 · wk-form4_1705108724.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,794

F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $18.61 to $19.57 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 136,904 RSUs.

F4 · balance_after: Reflects 15,558 shares previously disclosed as held indirectly; but have been determined to be held directly.

Read SEC document
January 09, 2024 Filed Jan 11, 2024 22:28 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 7,818 $19.78 $154,640.04
Disclosure

SEC source: 0001714899-24-000039 · wk-form4_1705012085.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,268,363

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.60 to $20.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
January 05, 2024 Filed Jan 10, 2024 00:33 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 17,483 $19.43 $339,694.69
Disclosure

SEC source: 0001714899-24-000035 · wk-form4_1704846791.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,276,181

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.36 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 51,060 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
January 05, 2024 Filed Jan 10, 2024 00:34 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 9,972 $19.43 $193,755.96
Disclosure

SEC source: 0001714899-24-000036 · wk-form4_1704846835.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 539,307

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.36 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 25,530 RSUs held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
January 05, 2024 Filed Jan 10, 2024 00:35 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 9,972 $19.43 $193,755.96
Disclosure

SEC source: 0001714899-24-000038 · wk-form4_1704846922.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 198,777

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.35 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 25,530 RSUs held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
January 05, 2024 Filed Jan 10, 2024 00:34 UTC SaleCommon Stock 3,208 $19.43 $62,331.44
Disclosure

SEC source: 0001714899-24-000037 · wk-form4_1704846873.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,591

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.37 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 24,002 RSUs.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:56 UTC
Watts Ryan J.Director · President and CEO
GrantStock Option (right to buy) · Derivative 268,560 $0.00 Strike: $20.33 $0.00
Disclosure

SEC source: 0001714899-24-000008 · wk-form4_1704495377.xml · derivative · entry 3

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 268,560

Underlying: Common Stock · 268,560 shares

Expires 2034-01-02

F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2025, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:56 UTC
Watts Ryan J.Director · President and CEO
GrantCommon Stock 89,520 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000008 · wk-form4_1704495377.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,957

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2025 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 221,897 RSU's as of January 4, 2024.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:57 UTC
Schuth Alexander O.COFO and Secretary
GrantStock Option (right to buy) · Derivative 161,160 $0.00 Strike: $20.33 $0.00
Disclosure

SEC source: 0001714899-24-000010 · wk-form4_1704495454.xml · derivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,160

Underlying: Common Stock · 161,160 shares

Expires 2034-01-02

F5 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2025, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:57 UTC
Schuth Alexander O.COFO and Secretary
GrantCommon Stock 53,720 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000010 · wk-form4_1704495454.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,157

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2025 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 136,721 RSU's as of January 4, 2024.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:57 UTC
Ho CaroleChief Medical Officer
GrantStock Option (right to buy) · Derivative 161,160 $0.00 Strike: $20.33 $0.00
Disclosure

SEC source: 0001714899-24-000009 · wk-form4_1704495415.xml · derivative · entry 4

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,160

Underlying: Common Stock · 161,160 shares

Expires 2034-01-02

F6 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2025, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:57 UTC
Ho CaroleChief Medical Officer
GrantCommon Stock 53,720 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000009 · wk-form4_1704495415.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,434

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2025 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 136,904 RSU's as of January 4, 2024.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 00:30 UTC
SATO VICKI LDirector
SaleCommon Stock 1,666 $23.39 $38,967.74
Disclosure

SEC source: 0001714899-23-000150 · wk-form4_1702945827.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,707

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F2 · balance_after: Includes 4,216 RSUs.

Read SEC document
November 15, 2023 Filed Nov 16, 2023 23:14 UTC
SATO VICKI LDirector
SaleCommon Stock 1,666 $19.13 $31,870.58
Disclosure

SEC source: 0001714899-23-000147 · wk-form4_1700176428.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,373

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F2 · balance_after: Includes 4,216 RSUs.

Read SEC document
October 16, 2023 Filed Oct 18, 2023 20:44 UTC
SATO VICKI LDirector
SaleCommon Stock 1,666 $20.66 $34,419.56
Disclosure

SEC source: 0001714899-23-000139 · wk-form4_1697661869.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,039

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F2 · balance_after: Includes 4,216 RSUs.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 20:45 UTC
SATO VICKI LDirector
SaleCommon Stock 40 $24.35 $974.00
Disclosure

SEC source: 0001714899-23-000138 · wk-form4_1695156311.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,705

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.32 to $24.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F4 · balance_after: Includes 4,216 RSUs.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 20:45 UTC
SATO VICKI LDirector
SaleCommon Stock 1,626 $23.60 $38,373.60
Disclosure

SEC source: 0001714899-23-000138 · wk-form4_1695156311.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,745

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.28 to $24.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 21:36 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,522 $23.17 $58,434.74
Disclosure

SEC source: 0001714899-23-000137 · wk-form4_1692999400.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 518,989

F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.87 to $23.36 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 21:30 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,522 $23.22 $58,560.84
Disclosure

SEC source: 0001714899-23-000136 · wk-form4_1692999010.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 182,809

F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted March 30, 2022.

F2 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 20:32 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 2,309 $22.59 $52,160.31
Disclosure

SEC source: 0001714899-23-000133 · wk-form4_1692822729.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,242,604

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: . The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.50 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 20:33 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,478 $22.59 $55,978.02
Disclosure

SEC source: 0001714899-23-000134 · wk-form4_1692822802.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 521,511

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.49 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 5,000 RSUs held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 20:34 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,478 $22.60 $56,002.80
Disclosure

SEC source: 0001714899-23-000135 · wk-form4_1692822872.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 185,331

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.55 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 5,000 RSUs held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 20:31 UTC SaleCommon Stock 1,419 $22.60 $32,069.40
Disclosure

SEC source: 0001714899-23-000132 · wk-form4_1692822662.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,799

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.51 to $22.99 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 31,502 RSUs.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 22:42 UTC
SATO VICKI LDirector
SaleCommon Stock 1,666 $24.30 $40,483.80
Disclosure

SEC source: 0001714899-23-000126 · wk-form4_1692312142.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,371

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.07 to $24.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 4,216 RSUs.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 22:19 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,772 $23.67 $65,613.24
Disclosure

SEC source: 0001714899-23-000124 · wk-form4_1692224345.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 518,989

F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.58 to $23.80 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 22:20 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,768 $23.79 $65,850.72
Disclosure

SEC source: 0001714899-23-000125 · wk-form4_1692224392.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 182,809

F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted March 30, 2023.

F2 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:13 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 2,526 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001714899-23-000123 · wk-form4_1692047595.xml · derivative · entry 4

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,118,091

Underlying: Common Stock · 2,526 shares

Expires 2025-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:13 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 2,526 $25.03 $63,225.78
Disclosure

SEC source: 0001714899-23-000123 · wk-form4_1692047595.xml · nonDerivative · entry 2

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,239,913

F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted August 18, 2022.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $25.00 to $25.11 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:13 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionCommon Stock 2,526 $0.68 $1,717.68
Disclosure

SEC source: 0001714899-23-000123 · wk-form4_1692047595.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,242,439

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Exercised shares were issued to the Watts Family 2015 Trust.

F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:11 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,853 $24.18 $68,985.54
Disclosure

SEC source: 0001714899-23-000121 · wk-form4_1692047483.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 521,761

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: . The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.99 to $24.35 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 5,625 RSUs held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:12 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,857 $24.15 $68,996.55
Disclosure

SEC source: 0001714899-23-000122 · wk-form4_1692047539.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 185,577

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.99 to $24.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 5,625 RSUs held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 21:10 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 9,702 $30.01 $291,157.02
Disclosure

SEC source: 0001714899-23-000109 · wk-form4_1689801007.xml · nonDerivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 518,989

F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022.

F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.04 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:10 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $5.28 $0.00
Disclosure

SEC source: 0001714899-23-000109 · wk-form4_1689801007.xml · derivative · entry 5

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,937

Underlying: Common Stock · 10,000 shares

Expires 2027-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vested monthly thereafter.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:10 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 10,000 $29.60 $296,000.00
Disclosure

SEC source: 0001714899-23-000109 · wk-form4_1689801007.xml · nonDerivative · entry 2

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 528,691

F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.33 to $29.94 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:10 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionCommon Stock 10,000 $5.28 $52,800.00
Disclosure

SEC source: 0001714899-23-000109 · wk-form4_1689801007.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 538,691

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Exercised shares were issued to the Schuth Family Trust.

F2 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:09 UTC
SATO VICKI LDirector
SaleCommon Stock 1,666 $29.60 $49,313.60
Disclosure

SEC source: 0001714899-23-000108 · wk-form4_1689800946.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,037

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.35 to $29.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 4,216 RSUs.

Read SEC document
June 28, 2023 Filed Jun 30, 2023 21:21 UTC
SATO VICKI LDirector
SaleCommon Stock 1,114 $29.98 $33,397.72
Disclosure

SEC source: 0001714899-23-000107 · wk-form4_1688160091.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,703

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.85 to $30.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F4 · balance_after: Includes 4,216 RSUs.

Read SEC document
June 28, 2023 Filed Jun 30, 2023 21:21 UTC
SATO VICKI LDirector
SaleCommon Stock 552 $29.55 $16,311.60
Disclosure

SEC source: 0001714899-23-000107 · wk-form4_1688160091.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 135,817

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.85 to $29.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 16, 2023 Filed Jun 20, 2023 22:28 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001714899-23-000105 · wk-form4_1687300068.xml · derivative · entry 4

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,120,617

Underlying: Common Stock · 50,000 shares

Expires 2025-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.

Read SEC document
June 16, 2023 Filed Jun 20, 2023 22:28 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 50,000 $31.40 $1,570,000.00
Disclosure

SEC source: 0001714899-23-000105 · wk-form4_1687300068.xml · nonDerivative · entry 2

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,239,913

F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted February 10, 2023.

F1 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
June 16, 2023 Filed Jun 20, 2023 22:28 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionCommon Stock 50,000 $0.68 $34,000.00
Disclosure

SEC source: 0001714899-23-000105 · wk-form4_1687300068.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,289,913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:08 UTC GrantStock Option (right to buy) · Derivative 12,649 $0.00 Strike: $30.92 $0.00
Disclosure

SEC source: 0001714899-23-000101 · wk-form4_1686002897.xml · derivative · entry 2

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,649

Underlying: Common Stock · 12,649 shares

Expires 2033-06-01

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:08 UTC GrantCommon Stock 4,216 $0.00 $0.00
Disclosure

SEC source: 0001714899-23-000101 · wk-form4_1686002897.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,713

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,472 unvested RSUs.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:07 UTC GrantStock Option (right to buy) · Derivative 12,649 $0.00 Strike: $30.92 $0.00
Disclosure

SEC source: 0001714899-23-000100 · wk-form4_1686002853.xml · derivative · entry 3

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,649

Underlying: Common Stock · 12,649 shares

Expires 2033-06-01

F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:07 UTC GrantCommon Stock 4,216 $0.00 $0.00
Disclosure

SEC source: 0001714899-23-000100 · wk-form4_1686002853.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,218

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 36,502 unvested RSUs.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:06 UTC GrantStock Option (right to buy) · Derivative 12,649 $0.00 Strike: $30.92 $0.00
Disclosure

SEC source: 0001714899-23-000099 · wk-form4_1686002790.xml · derivative · entry 5

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,649

Underlying: Common Stock · 12,649 shares

Expires 2033-06-01

F6 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:06 UTC GrantCommon Stock 4,216 $0.00 $0.00
Disclosure

SEC source: 0001714899-23-000099 · wk-form4_1686002790.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,874,572

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 4,216 unvested RSUs.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:05 UTC GrantStock Option (right to buy) · Derivative 12,649 $0.00 Strike: $30.92 $0.00
Disclosure

SEC source: 0001714899-23-000098 · wk-form4_1686002730.xml · derivative · entry 2

Klein Peter S · CIK 0001478007 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,649

Underlying: Common Stock · 12,649 shares

Expires 2033-06-01

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:05 UTC GrantCommon Stock 4,216 $0.00 $0.00
Disclosure

SEC source: 0001714899-23-000098 · wk-form4_1686002730.xml · nonDerivative · entry 1

Klein Peter S · CIK 0001478007 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,529

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 4,216 unvested RSUs.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.